NCT00813748View on ClinicalTrials.gov

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing

CompletedOBSERVATIONAL
Enrollment

118

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Allergic Asthma
Interventions
DRUG

Xolair

Trial Locations (7)

10022

Investigational Site, New York

19422

Investigational Site, Blue Bell

33596

Investigational Site, Valrico

60521

Investigational Site, Hinsdale

64111

Investigational Site, Kansas City

78229

Investigational Site, San Antonio

90025

Investigational Site, Los Angeles

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY